Marketing code change for devices to boost transparency in MedTech sector: AiMeD
Code capped the free evaluation samples at 2 per cent of domestic sales, with valuation to be recorded at stockist price if manufactured in-house, or at purchase price if sourced externally
Marketing code change for devices to boost transparency in MedTech sector: AiMeD
New Delhi: The Department of Pharmaceuticals’ (DoP) recent amendment to certain clauses of the marketing code for medical devices is set to boost transparency in MedTech sector, said the Association of Indian Medical Device Industry (AiMeD) on Wednesday.
The amendment to the Uniform Code for Marketing Practices in Medical Devices (UCMPMD), 2024, will enable manufacturers of medical devices to provide free evaluation samples to doctors.
This will help the healthcare professionals acquire hands-on experience in using the product.
However, the Code capped the free evaluation samples at 2 per cent of domestic sales, with valuation to be recorded at stockist price if manufactured in-house, or at purchase price if sourced externally.
As per the amendment, companies must disclose spending on samples, CME programmes, event sponsorships, and pre-approvals needed for specialist doctors' international travels, lodging, and hospitality in a newly prescribed annexure format.
